|

Decitabine for Injection Clinical Trials

1 actively recruiting trial

Also known as: 5-Aza-29-deoxycytidine, Dacogen

Pipeline

Phase 2: 1

Top Sponsors

  • First Affiliated Hospital of Zhejiang University1

Indications

  • Acute Myeloid Leukemia1
  • Myelodysplastic Syndromes1
  • Cancer1

Other1 trial

Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.